Monday, September 14, 2026

South Korea Ends 2023 Plan Early, Unveils New 5-Year North Korea Strategy

The South Korean government is terminating the Fourth Basic Plan for Inter-Korean Relations to create a new strategy focusing on peaceful coexistence.

2026 South-North Exchange: What’s Next for Inter-Korean Cooperation?

The Ministry of Unification plans to enhance inter-Korean exchanges, focusing on collaboration between central and local governments.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

Tag: regulatory changes

South Korea Eases Phase 3 Trial Requirements for Biosimilars Following U.S. and EU… Early Data Becomes Key Battleground

South Korea's MFDS eases Phase 3 trial requirements for biosimilars, aligning with global trends, enhancing early comparability importance.

U.S. FDA to Streamline IND Process: What It Means for Asian Biotech Competitiveness in 2027

The U.S. aims to streamline drug approval processes to compete with China and Australia in attracting clinical trials, enhancing biotech growth.

Top News

- Our Sponsors Ad -

Follow us